Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Increase in Short Interest

Biomerica, Inc. (NASDAQ:BMRA) saw a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 219,400 shares, an increase of 89.1% from the August 31st total of 116,000 shares. Based on an average daily trading volume, of 797,900 shares, the days-to-cover ratio is currently 0.3 days. Currently, 8.5% of the shares of the company are short sold. Currently, 8.5% of the shares of the company are short sold. Based on an average daily trading volume, of 797,900 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Biomerica in a research report on Saturday, September 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Biomerica has an average rating of “Sell”.

Biomerica Stock Up 1.4%

Shares of NASDAQ:BMRA opened at $2.80 on Monday. The company has a market cap of $8.04 million, a price-to-earnings ratio of -1.21 and a beta of 0.34. Biomerica has a fifty-two week low of $2.08 and a fifty-two week high of $10.16. The firm’s 50-day simple moving average is $3.06 and its 200-day simple moving average is $3.44.

Institutional Trading of Biomerica

An institutional investor recently bought a new position in Biomerica stock. Bulltick Wealth Management LLC bought a new position in shares of Biomerica, Inc. (NASDAQ:BMRA) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned 5.39% of Biomerica at the end of the most recent quarter. 22.28% of the stock is owned by institutional investors and hedge funds.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.